United States Migraine Drugs Market Report 2017

November 2017 | 108 pages | ID: U27CB978C31EN
QYResearch

Abstracts

In this report, the United States Migraine Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Migraine Drugs in these regions, from 2012 to 2022 (forecast).

United States Migraine Drugs market competition by top manufacturers/players, with Migraine Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca Plc.
• Allergan Plc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• GlaxoSmithKline Plc
• Eli Lilly & Co.
• Novartis AG
• Merck & Co., Inc.
• Valeant Pharmaceutical International, Inc.
• Janssen Pharmaceutical Company (Johnson & Johnson)
• Endo Pharmaceuticals Inc.
• Zosano Pharma Corporation
• Alder BioPharmaceuticals Inc.
• Avanir Pharmaceuticals, Inc.
• Eisai Co., Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Oral
• Injectable
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Migraine Drugs for each application, including

• Retail Pharmacies
• Hospital Pharmacies
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Migraine Drugs Market Report 2017

1 MIGRAINE DRUGS OVERVIEW

1.1 Product Overview and Scope of Migraine Drugs
1.2 Classification of Migraine Drugs by Product Category
  1.2.1 United States Migraine Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Migraine Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Oral
  1.2.4 Injectable
  1.2.5 Others
1.3 United States Migraine Drugs Market by Application/End Users
  1.3.1 United States Migraine Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Retail Pharmacies
  1.3.3 Hospital Pharmacies
  1.3.4 Others
1.4 United States Migraine Drugs Market by Region
  1.4.1 United States Migraine Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Migraine Drugs Status and Prospect (2012-2022)
  1.4.3 Southwest Migraine Drugs Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Migraine Drugs Status and Prospect (2012-2022)
  1.4.5 New England Migraine Drugs Status and Prospect (2012-2022)
  1.4.6 The South Migraine Drugs Status and Prospect (2012-2022)
  1.4.7 The Midwest Migraine Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Migraine Drugs (2012-2022)
  1.5.1 United States Migraine Drugs Sales and Growth Rate (2012-2022)
  1.5.2 United States Migraine Drugs Revenue and Growth Rate (2012-2022)

2 UNITED STATES MIGRAINE DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Migraine Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Migraine Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Migraine Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Migraine Drugs Market Competitive Situation and Trends
  2.4.1 United States Migraine Drugs Market Concentration Rate
  2.4.2 United States Migraine Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Migraine Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MIGRAINE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Migraine Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Migraine Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Migraine Drugs Price by Region (2012-2017)

4 UNITED STATES MIGRAINE DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Migraine Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Migraine Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Migraine Drugs Price by Type (2012-2017)
4.4 United States Migraine Drugs Sales Growth Rate by Type (2012-2017)

5 UNITED STATES MIGRAINE DRUGS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Migraine Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Migraine Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES MIGRAINE DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca Plc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Migraine Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Plc. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Allergan Plc.
  6.2.2 Migraine Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Allergan Plc. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer, Inc.
  6.3.2 Migraine Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer, Inc. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Teva Pharmaceutical Industries Ltd.
  6.4.2 Migraine Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Teva Pharmaceutical Industries Ltd. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 GlaxoSmithKline Plc
  6.5.2 Migraine Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 GlaxoSmithKline Plc Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Eli Lilly & Co.
  6.6.2 Migraine Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Eli Lilly & Co. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis AG
  6.7.2 Migraine Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis AG Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Merck & Co., Inc.
  6.8.2 Migraine Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merck & Co., Inc. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Valeant Pharmaceutical International, Inc.
  6.9.2 Migraine Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Valeant Pharmaceutical International, Inc. Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Janssen Pharmaceutical Company (Johnson & Johnson)
  6.10.2 Migraine Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Endo Pharmaceuticals Inc.
6.12 Zosano Pharma Corporation
6.13 Alder BioPharmaceuticals Inc.
6.14 Avanir Pharmaceuticals, Inc.
6.15 Eisai Co., Ltd.

7 MIGRAINE DRUGS MANUFACTURING COST ANALYSIS

7.1 Migraine Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Migraine Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Migraine Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Migraine Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MIGRAINE DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Migraine Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Migraine Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Migraine Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Migraine Drugs Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Migraine Drugs
Figure United States Migraine Drugs Market Size (K Units) by Type (2012-2022)
Figure United States Migraine Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Oral Product Picture
Figure Injectable Product Picture
Figure Others Product Picture
Figure United States Migraine Drugs Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Migraine Drugs by Application in 2016
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Migraine Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Migraine Drugs Sales (K Units) and Growth Rate (2012-2022)
Figure United States Migraine Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Migraine Drugs Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Migraine Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Migraine Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Migraine Drugs Sales Share by Players/Suppliers
Figure 2017 United States Migraine Drugs Sales Share by Players/Suppliers
Figure United States Migraine Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Migraine Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Migraine Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Migraine Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Migraine Drugs Revenue Share by Players/Suppliers
Table United States Market Migraine Drugs Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Migraine Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Migraine Drugs Market Share of Top 3 Players/Suppliers
Figure United States Migraine Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Migraine Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Migraine Drugs Product Category
Table United States Migraine Drugs Sales (K Units) by Region (2012-2017)
Table United States Migraine Drugs Sales Share by Region (2012-2017)
Figure United States Migraine Drugs Sales Share by Region (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Region in 2016
Table United States Migraine Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Migraine Drugs Revenue Share by Region (2012-2017)
Figure United States Migraine Drugs Revenue Market Share by Region (2012-2017)
Figure United States Migraine Drugs Revenue Market Share by Region in 2016
Table United States Migraine Drugs Price (USD/Unit) by Region (2012-2017)
Table United States Migraine Drugs Sales (K Units) by Type (2012-2017)
Table United States Migraine Drugs Sales Share by Type (2012-2017)
Figure United States Migraine Drugs Sales Share by Type (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Type in 2016
Table United States Migraine Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Migraine Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Migraine Drugs by Type (2012-2017)
Figure Revenue Market Share of Migraine Drugs by Type in 2016
Table United States Migraine Drugs Price (USD/Unit) by Types (2012-2017)
Figure United States Migraine Drugs Sales Growth Rate by Type (2012-2017)
Table United States Migraine Drugs Sales (K Units) by Application (2012-2017)
Table United States Migraine Drugs Sales Market Share by Application (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Application (2012-2017)
Figure United States Migraine Drugs Sales Market Share by Application in 2016
Table United States Migraine Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Migraine Drugs Sales Growth Rate by Application (2012-2017)
Table AstraZeneca Plc. Basic Information List
Table AstraZeneca Plc. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Plc. Migraine Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Allergan Plc. Basic Information List
Table Allergan Plc. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan Plc. Migraine Drugs Sales Growth Rate (2012-2017)
Figure Allergan Plc. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Allergan Plc. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Migraine Drugs Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Teva Pharmaceutical Industries Ltd. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Migraine Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceutical Industries Ltd. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Migraine Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Migraine Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Eli Lilly & Co. Basic Information List
Table Eli Lilly & Co. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly & Co. Migraine Drugs Sales Growth Rate (2012-2017)
Figure Eli Lilly & Co. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Eli Lilly & Co. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Migraine Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Migraine Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Merck & Co., Inc. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceutical International, Inc. Basic Information List
Table Valeant Pharmaceutical International, Inc. Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Valeant Pharmaceutical International, Inc. Migraine Drugs Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceutical International, Inc. Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceutical International, Inc. Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceutical Company (Johnson & Johnson) Basic Information List
Table Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceutical Company (Johnson & Johnson) Migraine Drugs Revenue Market Share in United States (2012-2017)
Table Endo Pharmaceuticals Inc. Basic Information List
Table Zosano Pharma Corporation Basic Information List
Table Alder BioPharmaceuticals Inc. Basic Information List
Table Avanir Pharmaceuticals, Inc. Basic Information List
Table Eisai Co., Ltd. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Migraine Drugs
Figure Manufacturing Process Analysis of Migraine Drugs
Figure Migraine Drugs Industrial Chain Analysis
Table Raw Materials Sources of Migraine Drugs Major Players/Suppliers in 2016
Table Major Buyers of Migraine Drugs
Table Distributors/Traders List
Figure United States Migraine Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Migraine Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Migraine Drugs Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Migraine Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Migraine Drugs Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Migraine Drugs Sales Volume (K Units) Forecast by Type in 2022
Table United States Migraine Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Migraine Drugs Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Migraine Drugs Sales Volume (K Units) Forecast by Application in 2022
Table United States Migraine Drugs Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Migraine Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Migraine Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Migraine Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources